Effect of SARS-CoV-2 variant emergence on efficacy of neutra

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

Related Keywords

United States , India , Bio Shutterstock , Pfizer , Biochemical Society Transactions , Drug Administration , Huen Structure Bio , United States Food , Antibodies , Coronavirus Disease Covid 19 , Efficacy , Cars , Ars Cov 2 , Ce2 , Ngiotensin , Ngiotensin Converting Enzyme 2 , Ntibody , Fell , Coronavirus , Nzyme , Revolution , Global Health , Lycoprotein , Immunity , Immunization , N Vitro , Utation , Anoparticles , Pandemic , Protein , Eceptor , Espiratory , Ibonucleic Acid , Na , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Otrovimab , Spike Protein , Yndrome , T Cell , Vaccine , Virus ,